Assignee
LABYRX IMMUNOLOGIC THERAPEUTICS USA LTD
US·0 granted patents·2 pending applications·0 citations·filing 2019–2020
Top patents by PatentIndex Score
2 records- 0149US2022409709A1Labyrinthin-based peptides for cancer immunotherapies and uses thereofLABYRX IMMUNOLOGIC THERAPEUTICS USA LTD·Filed 2019·Application pending·0 cites
- 0248US2022089719A1Constructs targeting labyrinthin or a portion thereof and uses thereofLABYRX IMMUNOLOGIC THERAPEUTICS USA LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LABYRX IMMUNOLOGIC THERAPEUTICS USA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →